HomeNPCE • NASDAQ
add
Neuropace Inc
Previous close
$17.08
Day range
$16.42 - $17.85
Year range
$5.45 - $17.85
Market cap
573.65M USD
Avg Volume
204.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 22.52M | 24.28% |
Operating expense | 22.49M | 7.66% |
Net income | -6.59M | 26.17% |
Net profit margin | -29.25 | 40.60% |
Earnings per share | -0.21 | 34.38% |
EBITDA | -5.10M | 32.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 66.26M | 12.41% |
Total assets | 110.20M | 11.48% |
Total liabilities | 85.94M | 1.68% |
Total equity | 24.27M | — |
Shares outstanding | 32.80M | — |
Price to book | 23.08 | — |
Return on assets | -12.56% | — |
Return on capital | -14.40% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.59M | 26.17% |
Cash from operations | -7.48M | 0.61% |
Cash from investing | -37.00K | -101.54% |
Cash from financing | 21.11M | 29,216.67% |
Net change in cash | 13.59M | 368.56% |
Free cash flow | -4.61M | 14.83% |
About
Founded
1997
Website
Employees
195
